These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2732736)

  • 1. Familial lysinuric protein intolerance presenting as coma in two adult siblings.
    Shaw PJ; Dale G; Bates D
    J Neurol Neurosurg Psychiatry; 1989 May; 52(5):648-51. PubMed ID: 2732736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ornithine metabolism in hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome, lysinuric protein intolerance and gyrate atrophy fibroblasts.
    Botschner J; Smith DW; Simell O; Scriver CR
    J Inherit Metab Dis; 1989; 12(1):33-40. PubMed ID: 2501580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged coma and isoelectric electroencephalogram in a child with lysinuric protein intolerance.
    Chan H; Billmeier GJ; Molinary SV; Tucker HN; Shin BC; Schaffer A; Cavallo K
    J Pediatr; 1977 Jul; 91(1):79-81. PubMed ID: 874670
    [No Abstract]   [Full Text] [Related]  

  • 4. Necropsy findings in lysinuric protein intolerance.
    McManus DT; Moore R; Hill CM; Rodgers C; Carson DJ; Love AH
    J Clin Pathol; 1996 Apr; 49(4):345-7. PubMed ID: 8655715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lysinuric protein intolerance: a severe hyperammonemia secondary to l-arginine deficiency (author's transl)]].
    Coude FX; Ogier H; Charpentier C; Cathelineau L; Grimber G; Parvy P; Saudubray JM; Frezal J
    Arch Fr Pediatr; 1981 Dec; 38 Suppl 1():829-35. PubMed ID: 6800334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperammonemia due to a defect in hepatic ornithine transcarbamylase.
    Sunshine P; Lindenbaum JE; Levy HL; Freeman JM
    Pediatrics; 1972 Jul; 50(1):100-11. PubMed ID: 5038084
    [No Abstract]   [Full Text] [Related]  

  • 7. Lysinuric protein intolerance presenting deficiency of argininosuccinate synthetase.
    Ono N; Kishida K; Tokumoto K; Watanabe M; Shimada Y; Yoshinaga J; Fujii M
    Intern Med; 1992 Jan; 31(1):55-9. PubMed ID: 1568044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An inherited enzyme deficiency resulting in hyperammonaemia and coma in a burn patient.
    Field TO; Dominic WJ; Hansbrough JF
    Burns Incl Therm Inj; 1987 Jun; 13(3):229-31. PubMed ID: 3607566
    [No Abstract]   [Full Text] [Related]  

  • 9. Improving a Rare Metabolic Disorder Through Kidney Transplantation: A Case Report of a Patient With Lysinuric Protein Intolerance.
    IJzermans T; van der Meijden W; Hoeks M; Huigen M; Rennings A; Nijenhuis T
    Am J Kidney Dis; 2023 Apr; 81(4):493-496. PubMed ID: 36223829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutrient intake in lysinuric protein intolerance.
    Tanner LM; Näntö-Salonen K; Venetoklis J; Kotilainen S; Niinikoski H; Huoponen K; Simell O
    J Inherit Metab Dis; 2007 Oct; 30(5):716-21. PubMed ID: 17588131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent stupor due to lysinuric protein intolerance.
    Moosa NV; Minal D; Rao AN; Kumar A
    Neurol India; 2005 Sep; 53(3):333-4. PubMed ID: 16230804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral supplementation corrects plasma lysine concentrations in lysinuric protein intolerance.
    Lukkarinen M; Näntö-Salonen K; Pulkki K; Aalto M; Simell O
    Metabolism; 2003 Jul; 52(7):935-8. PubMed ID: 12870174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysinuric protein intolerance presenting as coma in a middle-aged man.
    Gare M; Shalit M; Gutman A
    West J Med; 1996 Oct; 165(4):231-3. PubMed ID: 8987436
    [No Abstract]   [Full Text] [Related]  

  • 14. Growth hormone deficiency in a patient with lysinuric protein intolerance.
    Esposito V; Lettiero T; Fecarotta S; Sebastio G; Parenti G; Salerno M
    Eur J Pediatr; 2006 Nov; 165(11):763-6. PubMed ID: 16775724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral administration of urea cycle intermediates in lysinuric protein intolerance: effect on plasma and urinary arginine and ornithine.
    Rajantie J; Simell O; Perheentupa J
    Metabolism; 1983 Jan; 32(1):49-51. PubMed ID: 6401349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperammonemia in lysinuric protein intolerance.
    Kato T; Mizutani N; Ban M
    Pediatrics; 1984 Apr; 73(4):489-92. PubMed ID: 6424086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperexcretion of homocitrulline in a Malaysian patient with lysinuric protein intolerance.
    Habib A; Md Yunus Z; Azize NA; Ch'ng GS; Ong WP; Chen BC; Hsu HT; Wong KJ; Pitt J; Ngu LH
    Eur J Pediatr; 2013 Sep; 172(9):1277-81. PubMed ID: 23358709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysinuric protein intolerance. Urinary amino acid excretion at 2 and 9 days of age.
    Candito M; Vianey-Saban C; Ferraci JP; Bébin B; Chazalette JP; Sebag F; Mathieu M; Chambon P
    J Inherit Metab Dis; 1994; 17(2):252-3. PubMed ID: 7967486
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and laboratory study in 22 patients with inherited hyperammonemic syndromes.
    Rottem M; Statter M; Amit R; Brand N; Bujanover Y; Yatziv S
    Isr J Med Sci; 1986 Nov; 22(11):833-6. PubMed ID: 3793440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The dibasic amino acid metabolic disorders].
    Shimizu H
    Nihon Rinsho; 1992 Jul; 50(7):1555-60. PubMed ID: 1404883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.